title: Phosphatidylserine-induced modulation of the immune response in mice: effect of intravenous administration.
abstract: The action of phosphatidylserine on the immune response has been examined in mice after the intravenous administration of phospholipid or exposing cultured splenocytes to the action of phosphatidylserine vesicles. Phosphatidylserine (5-25 mg/kg) reduces the T-dependent and the T-independent antibody production. This effect is observed when the phospholipid is injected before (4 h) but not after (24 h) the immunization. The decreased influence of phosphatidylserine injected 24 h before the immunization indicates the reversibility of the action of phospholipid. The effect on the immune system may in part reflect a direct interaction with lymphocytes, since phosphatidylserine (12-60 microM) decreases the production of T-cell growth factors (mainly interleukin-2) elicited by mitogens in cultured spleen cells and reduces the expression of growth factor receptors in the same cells activated by mitogens. In addition, the activity of T-helper cells is found to be reduced in mice receiving the injection of phosphatidylserine. By contrast, the antigen processing and presentation by macrophages is not affected. The data suggest that the intravenous injection of phosphatidylserine vesicles in mice is followed by a transient decrease of lymphocyte activity.
authors.affiliation: Fidia Neurobiological Research Laboratories, Abano Terme, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Ponzin
authors.forename: C
authors.initials: C
authors.lastname: Mancini
authors.forename: G
authors.initials: G
authors.lastname: Toffano
authors.forename: A
authors.initials: A
authors.lastname: Bruni
authors.forename: G
authors.initials: G
authors.lastname: Doria
mesh_terms: D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D007275:Injections, Intravenous; D007376:Interleukin-2 / Q000096:biosynthesis; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology; D008246:Lysophospholipids / Q000494:pharmacology; D008264:Macrophages / Q000187:drug effects; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D010718:Phosphatidylserines / Q000008:administration & dosage / Q000494:pharmacology*; D006377:T-Lymphocytes, Helper-Inducer / Q000187:drug effects
chemical_list: D007376:Interleukin-2; D008246:Lysophospholipids; D010718:Phosphatidylserines; C025059:lysophosphatidylserine